EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of intravenous mixed micelle phytomenadione (vitamin K1 ) and traditional therapies for the treatment of anticoagulant rodenticide toxicosis in dogs and cats: a retrospective study

G Agostini iD, E T Mooney, Elw Wilkie, J D White

Australian Veterinary Journal · 2025

DOI: 10.1111/avj.70004 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Australian Veterinary Journal, 2025. Verfasst von G Agostini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Veterinary Specialists, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Rodenticides, Dog Diseases, Cat Diseases, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ingestion of anticoagulant rodenticide is among the most common toxicoses seen in dogs and cats. Current treatment protocols in veterinary patients recommend the use of plasma‐containing blood products to replenish clotting factors. Intravenous mixed‐micelle phytomenadione (MMP) represents a safe and cost‐effective alternative to traditional therapy.

Objective

Description of the use of MMP as a treatment for clinical anticoagulant rodenticide toxicosis, focusing on the incidence of adverse reactions and restoration of coagulation times. Duration of hospitalisation, cost of treatment and need for red blood cell‐containing products were compared between two cohorts of patients receiving MMP and traditional therapy with blood products.

Methods

Retrospective search of electronic medical records from two Australian emergency and referral hospitals for patients treated for clinical anticoagulant rodenticide toxicosis between July 2021 and July 2024.

Results

74 animals (71 dogs, 3 cats) were treated for anticoagulant rodenticide toxicosis within the study period. 44 dogs comprised the “control” group, and 27 dogs and 3 cats comprised the “MMP” group. One dog was excluded from each group. There was no difference in survival to discharge between groups ( P = 0.28). No adverse reactions to MMP were recorded. Dogs within the “control” group were significantly more likely to receive fresh frozen plasma (FFP), there was no difference in requirement for red blood cell‐containing products between groups ( P = 1). Animals in the MMP group had significantly shorter hospitalisation time when compared with the control group ( P = 0.01).

Conclusion

Based on red cell transfusion requirements and survival data in this case series, it can be suggested that MMP is a comparable and cost‐effective treatment alternative for clinical anticoagulant rodenticide toxicosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RodenticidesDog DiseasesCat DiseasesAnticoagulantsVitamin K 1AnimalsDogsRetrospective StudiesCatsMaleFemale

Stichwörter der Autor:innen

anticoagulant rodenticidecoagulopathy: toxicologyphytomenadionevitamin K

Substanzen

RodenticidesAnticoagulantsVitamin K 1

Autor:innen und Institutionen

  • Queensland Veterinary Specialists, Brisbane, Queensland, Australia.
  • Small Animal Specialist Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: G Agostini

Zitieren

APA

Agostini, G., Mooney, E. T., Wilkie, E., & White, J. D. (2025). Comparison of intravenous mixed micelle phytomenadione (vitamin K1 ) and traditional therapies for the treatment of anticoagulant rodenticide toxicosis in dogs and cats: a retrospective study. Australian Veterinary Journal. https://doi.org/10.1111/avj.70004

Vancouver

Agostini G, Mooney ET, Wilkie E, White JD. Comparison of intravenous mixed micelle phytomenadione (vitamin K1 ) and traditional therapies for the treatment of anticoagulant rodenticide toxicosis in dogs and cats: a retrospective study. Australian Veterinary Journal. 2025. doi:10.1111/avj.70004

BibTeX
@article{Agostini2025,
  author = {Agostini, G and Mooney, E T and Wilkie, Elw and White, J D},
  title = {Comparison of intravenous mixed micelle phytomenadione (vitamin K1 ) and traditional therapies for the treatment of anticoagulant rodenticide toxicosis in dogs and cats: a retrospective study},
  journal = {Australian Veterinary Journal},
  year = {2025},
  doi = {10.1111/avj.70004}
}
Kostenlos starten →